Browsing by Author Karavasilis, V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 7 to 26 of 31 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunctionBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Piperidou, C.; Soulti, K.; Pavlidis, N.24-Nov-2015-
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionIoachim, E.; Charchanti, A.; Briasoulis, E.; Karavasilis, V.; Tsanou, H.; Arvanitis, D. L.; Agnantis, N. J.; Pavlidis, N.24-Nov-2015-
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinomaTsanou, E.; Ioachim, E.; Briasoulis, E.; Damala, K.; Charchanti, A.; Karavasilis, V.; Pavlidis, N.; Agnantis, N. J.24-Nov-2015-
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic studyBamias, A.; Syrigos, K.; Fountzilas, G.; Tzamakou, E.; Soulti, K.; Karavasilis, V.; Alamanos, Y.; Christodoulou, C.; Pavlidis, N.24-Nov-2015-
Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxelBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Rammou, D.; Soulti, K.; Piperidou, C.; Pavlidis, N.24-Nov-2015-
Invasive thymoma: a clinical study of 23 casesFroudarakis, M. E.; Tiffet, O.; Fournel, P.; Briasoulis, E.; Karavasilis, V.; Cuilleret, J.; Vergnon, J. M.24-Nov-2015-
Leiomyosarcoma as a second metachronous malignant neoplasm following colon adenocarcinoma. A case report and review of the literatureMavrodontidis, A.; Zalavras, C.; Skopelitou, A.; Karavasilis, V.; Briasoulis, E.24-Nov-2015-
Matrix metalloproteinases in carcinoma of unknown primaryKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015-
Megestrol activity in recurrent adult type granulosa cell tumour of the ovaryBriasoulis, E.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Metastatic breast carcinoma confined to bone: portrait of a clinical entityBriasoulis, E.; Karavasilis, V.; Kostadima, L.; Ignatiadis, M.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Motion Segmentation by Model-Based Clustering of Incomplete TrajectoriesKaravasilis, V.; Blekas, K.; Nikou, C.11-Dec-2015-
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaBriasoulis, E.; Rontogianni, D.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation studyBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Haidou, C.; Piperidou, C.; Pavlidis, N.24-Nov-2015-
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case studyPappas, P.; Karavasilis, V.; Briasoulis, E.; Pavlidis, N.; Marselos, M.24-Nov-2015-
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsSainis, I.; Vareli, K.; Karavasilis, V.; Briasoulis, E.24-Nov-2015-
Proteolysis and angiogenesis in cancer of unknown primary. A clinicopathological studyKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kalofonos, H.; Fountzilas, G.; Kitsou, E.; Fotsis, T.; Pavlidis, N.24-Nov-2015-
Pseudomonas fluorescens infections in clinical practicePappas, G.; Karavasilis, V.; Christou, L.; Tsianos, E. V.24-Nov-2015-
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvisKatsanos, K. H.; Briasoulis, E.; Tsekeris, P.; Batistatou, A.; Bai, M.; Tolis, C.; Capizzello, A.; Panelos, I.; Karavasilis, V.; Christodoulou, D.; Tsianos, E. V.24-Nov-2015-
Revisiting bleomycin from pathophysiology to safe clinical useFroudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E.24-Nov-2015-
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactionsBriasoulis, E.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-